시사 이슈US
Experimental therapy gantenerumab fails to slow or improve Alzheimer's memory loss in clinical trials
CNN Health|2022.11.15
An experimental treatment, gantenerumab, failed to help people at high risk of memory loss from Alzheimer's or those who were in the early phases of the disease, the manufacturer said Monday.
An experimental treatment, gantenerumab, failed to help people at high risk of memory loss from Alzheimer's or those who were in the early phases of the disease, the manufacturer said Monday.
원문 기사 보기CNN Health에서 원문을 확인할 수 있습니다
